Repligen Corporation (RGEN)
NASDAQ: RGEN
· Real-Time Price · USD
124.56
3.98 (3.30%)
At close: Sep 05, 2025, 3:59 PM
124.00
-0.45%
After-hours: Sep 05, 2025, 07:16 PM EDT
Repligen Revenue Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | 169.14M | 174M | 154.83M | 154.04M | 151.31M | 155.47M | 141.16M | 159.13M | 182.62M | 186.51M | 200.71M | 207.6M | 206.36M | 186.49M | 178.18M | 162.92M | 142.74M | 108.61M | 94.03M | 87.43M | 76.06M | 69.4M | 69.42M | 70.67M | 51.85M | 49.5M | 47.74M |
| Product Revenue Growth | -2.79% | +12.38% | +0.52% | +1.80% | -2.68% | +10.14% | -11.30% | -12.86% | -2.09% | -7.07% | -3.32% | +0.60% | +10.66% | +4.66% | +9.36% | +14.14% | +31.42% | +15.51% | +7.55% | +14.95% | +9.60% | -0.03% | -1.77% | +36.30% | +4.75% | +3.68% | n/a |
| Royalty Revenue | 35K | n/a | 37K | 35K | 36K | n/a | 36K | 36K | 39K | 247K | 33K | 36K | 37K | 36K | 39K | 40K | 100K | 33K | 31K | 30K | 30K | 78K | 26K | 22K | 93K | 29K | -12K |
| Royalty Revenue Growth | n/a | n/a | +5.71% | -2.78% | n/a | n/a | 0.00% | -7.69% | -84.21% | +648.48% | -8.33% | -2.70% | +2.78% | -7.69% | -2.50% | -60.00% | +203.03% | +6.45% | +3.33% | 0.00% | -61.54% | +200.00% | +18.18% | -76.34% | +220.69% | -341.67% | n/a |
Revenue by Geography
| Period Ending | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|
| All Other Revenue | 62K | 55K | 243K |
| All Other Revenue Growth | +12.73% | -77.37% | n/a |
| Asia And Australia Revenue | 6.08M | 5.62M | 19.4M |
| Asia And Australia Revenue Growth | +8.15% | -71.05% | n/a |
| Europe Revenue | 19.33M | 19.58M | 20.24M |
| Europe Revenue Growth | -1.28% | -3.27% | n/a |
| North America Revenue | 24.06M | 22.48M | n/a |
| North America Revenue Growth | +7.04% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 71.23M | 71.25M | 63.74M | 75.61M | 64.7M | 60.99M | 57.51M | 55.47M | 48.97M | 56.17M | 53.24M | 53.64M | 54.65M | 54.3M | 52.06M | 48.37M | 44.34M | 39.09M | 36.34M | 29.05M | 26.73M | 27.5M | 28.29M | 24.63M | 23.7M | 19M | 17.98M | 15.86M | 16.59M | 15.9M | 16.14M | 15M | 11.19M | 9.18M | 8.57M | 7.13M | 8.14M | 7.02M | 6.47M | 5.96M | 6.24M | 6.02M |
| Selling, General, and Administrative Revenue Growth | -0.04% | +11.78% | -15.70% | +16.87% | +6.09% | +6.04% | +3.69% | +13.27% | -12.83% | +5.51% | -0.76% | -1.84% | +0.64% | +4.31% | +7.62% | +9.09% | +13.42% | +7.57% | +25.10% | +8.70% | -2.81% | -2.78% | +14.85% | +3.92% | +24.74% | +5.69% | +13.35% | -4.41% | +4.35% | -1.53% | +7.65% | +34.09% | +21.81% | +7.18% | +20.20% | -12.44% | +15.99% | +8.42% | +8.63% | -4.54% | +3.61% | n/a |
| Research and Development Revenue | 13.96M | 12.92M | 11.68M | 9.71M | 10.57M | 11.24M | 10.29M | 10.58M | 9.71M | 12.15M | 11.11M | 10.23M | 10.44M | 12.15M | 9.12M | 9.15M | 8.39M | 7.61M | 6.72M | 4.42M | 4.34M | 4.7M | 5.17M | 5.43M | 5.23M | 3.62M | 3.1M | 3.6M | 5.78M | 3.29M | 3.07M | 2M | 1.86M | 1.74M | 2.04M | 1.89M | 1.89M | 1.54M | 1.43M | 1.49M | 1.25M | 1.57M |
| Research and Development Revenue Growth | +8.00% | +10.68% | +20.26% | -8.18% | -5.90% | +9.27% | -2.76% | +8.97% | -20.14% | +9.37% | +8.65% | -2.03% | -14.11% | +33.29% | -0.38% | +9.12% | +10.21% | +13.24% | +52.01% | +1.98% | -7.78% | -9.09% | -4.70% | +3.75% | +44.50% | +16.81% | -13.94% | -37.70% | +75.79% | +7.17% | +53.32% | +7.58% | +6.77% | -14.61% | +8.17% | -0.21% | +22.81% | +7.55% | -3.96% | +19.05% | -20.16% | n/a |